by RCM STI | May 21, 2024 | RCM Newsletter
New Codes for Covid-19 Monoclonal Antibody On March 22, 2024, the FDA released an emergency use authorization for the PEMGARDA monoclonal antibody product for pre-exposure prophylaxis of COVID-19. New Product Code – Q0224 Administration Code – M0224 Click here for...
by RCM STI | Apr 21, 2024 | RCM Newsletter
Waystar Clearinghouse STI RCM is transitioning all Practice Manager based clients from Change Healthcare to Waystar clearinghouse. Make note during this transition, we are still actively sending claims to payers as we have, until set up and the enrollments are...
by RCM STI | Mar 21, 2024 | RCM Newsletter
CMS Suspends Appropriate Use Criteria for Advanced Diagnostic Imaging (AUC) Program CMS recently released a transmittal for Medicare Administrative Contractors (MACs) to put into place the agency’s suspension of the Appropriate Use Criteria for Advanced...
by RCM STI | Feb 21, 2024 | RCM Newsletter
Excellus BCBS Updated NDC/HCPCS Codes When Billing for Depo-Provera® Effective February 15, 2024, providers can bill J1050 or J3490 for Depo-Provera injections for all lines of business. For all lines of business*, effective February 15, 2024, please submit all claims...
by RCM STI | Jan 21, 2024 | RCM Newsletter
Humana Military Referral Change As of December 18, 2023, Humana Military will no longer provide basic referral status information through the call center. Providers must instead use provider self-service on HumanaMilitary.com or call the automated and interactive...
by RCM STI | Dec 21, 2023 | RCM Newsletter
Best Practices Moving into the New Year As the new year approaches, here are some reminders to support a healthy revenue cycle: Verify patient eligibility and benefits – Many patients will have new insurance at the start of the year. Keep claim denials at bay by...
